Links to publications that use this kit:
Chen Y-H, Wu Y-W, Yang W-S, Wang S-S, Lee C-M, et al. Relationship between Bone Mineral Density and Serum Osteoprotegerin in Patients with Chronic Heart Failure.
PLoS ONE 7(8): e44242. doi:10.1371/journal.pone.0044242
Hisashi Masuyama et al., Potential interaction of brain natriuretic peptide with hyperadiponectinemia in preeclampsia.
AJP - Endo January 10, 2012 ajpendo.00548.2011
Tonne JM et al., Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes.
Clin Chem. 2011 Jun;57(6):864-73. doi: 10.1373/clinchem.2010.157438. Epub 2011 Apr 11.
Yagci et al. Serum levels of natriuretic peptides in patients with Behcet's disease.
Clin Rheumatol. 2008 Sep;27(9):1153-8.
Sans Capdevila et al. Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study.
Pediatrics. 2008 May;121(5):e1208-14.
Gürgün et al. The effects of short term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failure.
Int J Cardiol. 2008 Jan 11;123(2):102-7.
Sevimli et al. The effect of carvedilol on big endothelin, atrial and brain natriuretic peptide levels in patients with congestive heart failureTürk Kardiyol Dern Arş 2007; 35:412-416Wang et al. AlbuBNP, a recombinant B-type natriuretic peptide and human serum albumin fusion hormone, as a long-term therapy of congestive heart failure.Pharm Res. 2004 Nov;21(11):2105-11.